FDA Clears AI Model to Help Detect Heart Attacks from ECG Data
The U.S. Food and Drug Administration has granted clearance to an artificial intelligence model designed to analyze electrocardiogram readings for signs of heart attacks. The system, referred to as the "Queen of Hearts," uses machine learning to examine ECG data—a non-invasive test that records the heart's electrical activity.
ECG-based AI tools have been an area of growing research interest, as they may help flag abnormalities that could indicate acute myocardial infarction. Such systems are typically intended to support clinical decision-making rather than replace physician judgment, assisting healthcare providers in triaging or interpreting results more efficiently.
The authorization represents another step in the broader integration of AI into cardiovascular diagnostics, where machine learning models are increasingly being explored for their potential to improve early detection of cardiac conditions.